Global Homeopathy Products Market Outlook

Pages : 185 | Category: | Publishers: Goldstein Research


Global Homeopathy Product Market
Market Overview
Homeopathy is an alternative to help in treating and curing chronic illnesses. Homoeopathy run through in almost 80 countries of the world and is quiet effective for communicable and non-communicable diseases and chronic diseases for all age groups. For instance, Oscillococcinum, a homeopathic medicine for ‘flu, is one of the bestselling over-the-counter medicines in France. There are opportunities for the homeopathic and herbal remedies sector, as market size to increase to USD 7.5 billion in 2017 as people are becoming proactive about their health. Moreover growth is fueled by availability of these products in mass retailer.
Goldstein Research analyst forecast the homeopathy product market to grow at a CAGR of 16.8% during the forecast period 2016-2024 and attain the revenue of USD 16.2 billion by 2024.
Covered In This Global Homeopathy Product Market Report
The report covers the present ground scenario and the future growth prospects of the homeopathy product market for 2016-2024 along with the adoption rate in every region. We calculated the market size and revenue share on the basis of revenue generated from the sales of homeopathy products in the various applications and number of worldwide homeopathy users across the globe.
Global Homeopathy Product Market Segmentation
Based on Product Type
? Tincture
? Dilutions
? Ointments
? Tablets
? Others
Based on Treatment
• Auto-isopathy
• Classical homeopathy
• Clinical homeopathy
• Complex homeopathy
• Homotoxicology
• Isopathy
• Pluralistic homeopathy
Based on Source
? Plants
? Animals
? Minerals
Based on Application
? Analgesic and Antipyretic
? Respiratory
? Neurology
? Immunology
? Gastroenterology
? Dermatology
? Others
Based on Geography
? North America (U.S. & Canada) Homeopathy Product Market
? Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Homeopathy Product Market
? Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Homeopathy Product Market
? Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Homeopathy Product Market
? Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Homeopathy Product Market
On the basis of product type, dilution is anticipated to account for USD 6.5 billion by 2024, registering a considerable CAGR of 16.9% over the forecast year and accounted for 35% market share of total homeopathy product market in 2016 owing to the necessity of dosage forms. Tincture and ointment are expected to be the promising future markets.
Homeopathy Product Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.
Our global market report comprises of the following companies as the key players in the Homeopathy Product market: Boiron Group, Biologische Heilmittel Heel GmbH, A Nelson & Co Ltd, GMP Laboratories of America, Inc., Standard Homeopathic Company (Hyland’s, Inc.), Washington Homeopathic Products, Inc., Homeocan inc., Hahnemann Laboratories, Inc., Mediral International Inc., and Ainsworths Ltd.
According to our global market study on the basis of extensive primary and secondary research: “One of the growing trend of homeopathy market is its integration with allopathy rather than being pursued high-handed as a rival alternative to conventional treatment.”
According to the report, major driver for expansion of homeopathy product market is its explicitness to the patient physiology (customization). The choice of remedy is based not only on the symptoms, but also on the patient’s emotional state, lifestyle, and other factors. Thus, two people with the same ailment may receive different treatments.
Further, the report states that one challenge in homeopathy is that it is not an evidence-based market as no good-quality; well-designed studies with enough participants for a meaningful result reported either that homeopathy caused greater health improvements than placebo, or caused health improvements like another treatment.
Based on geography, Europe holds the largest market share of 38% in 2016 while APAC is projected to witness a robust growth with a CAGR of 17.5% over the forecast years. UAE stands out as having the highest scope for homeopathy and a significant evolution towards the practice of homeopathy is observed in three countries: India, Brazil and Mexico.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
For a full detailed overview, send us the sample request.
Key questions answered in this Homeopathy Product report
• What is the total market size by 2024 and what would be the expected growth rate of the market?
• What is the adoption rate of Homeopathy Product in 2015-16 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?
We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements